Page 6 - Buzz Show News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sponsored Content Release FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content ...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Zhongchao Inc. Shares Rise After Renewing its Contract with China Association of Health Promotion and Education and GlaxoSmithKline” Zhongchao Inc. (NASDAQ: ZCMD) shot up just over 87% in premarket trading after the company renewed its partnership with the China Association for Health Promotion and Education and GlaxoSmithKline Investment Limited. The partnership seeks to continue the medical education program “Pulmonary Arterial Hypertension Online Course – Connections with Famous Hospitals”, which...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “NLS Pharmaceutics Ltd. Surges Amid License Agreement with Novartis Pharma AGs”FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “NLS Pharmaceutics Ltd. Surges Amid License Agreement with Novartis Pharma AGs” NLS Pharmaceutics Ltd. (NASDAQ: NLSP) shot up over 109% in premarket trading after the Company had entered into a License Agreement with Novartis Pharma AG. The agreement grants NLS all of the available...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Second Sight Medical Receives FDA Approval for the Argus 2s Retinal Prosthesis System” Second Sight Medical (NASDAQ: EYES) Products surged just under 60% in premarket trading after the company announced the U.S. Food and Drug Administration has approved the Argus 2s Retinal Prosthesis System. The Company expects that the redesigned set of external hardware initially for use in combination with previously implanted Argus II systems for the treatment of retinitis pigmentosa, will be adapted to be the extern...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ Revolution Acceleration RIses Amid SPAC deal for robotics firm Berkshire Grey” Revolution Acceleration Acquisition Corp (NYSE: RAAC) gained over 17% in premarket trading after Berkshire Grey entered into a definitive agreement with the Company. The agreement will now create a leading publicly listed robotics and automation solutions company with a post-transaction equity value of up to $2.7 billion. First, the impact of government policies on our economic and environmental systems will continue to grow an...